TP53 and familial pancreatic carcinoma: Thus, it is highly likely that intracellular balance of the endogenous expression levels between pro-apoptotic TAp63 and pro-oncogenic mutant p53 might be a vital determinant of pancreatic cancer cell fate in response to GEM.